Search terms
Results 1 - 10 of 10 - ordered by :

14:00 P3296 Asymmetrical dimethylarginine as a mediator of endothelial dysfunction in acute inflammation at different disease stages Alexios ANTONOPOULOS (Athens, GR) 14:00 P3297 Safe exclusion of ...

Poster session 4: Peripheral vascular disease

Date : 29/08/2011 Item size : 187346 bytes

14:00 P2339 The role of metabolic syndrome and the ventricular geometry The evaluation of TOD in hypertension study Athanasios TRIANTAFYLLOU (Athens, GR) 14:00 P2340 The influence of arterial ...

Poster session 3: Target organ damage in hypertension II

Date : 31/08/2014 Item size : 75180 bytes

11:00 P817 SCAD management, controversies; in the stent era Abtehale AL-HUSSAINI (Leicester, United Kingdom) 11:00 P818 Outcome of patients with atrial fibrillation submitted to percutaneous coronary ...

Poster session 1: Early and late outcomes after PCI II

Date : 29/08/2015 Item size : 98827 bytes

14:30 P492 Can cardiovascular risk factors be predictors of reperfusion strategy? P Sousa (Lisboa, PT) 14:30 P493 Sudden coronary death in average russian population A Boytsov (Moscow, RU) 14:30 P494 ...

Poster session 4

Date : 16/04/2011 Item size : 726462 bytes

14:00 P1064 The natural course of heart failure with preserved ejection fraction (HFpEF) - insights from an exploratory echocardiographic registry Matthias KOSCHUTNIK (Vienna, Austria) 14:00 P1065 ...

Poster session 5: The imaging examination and quality assessment

Date : 09/12/2016 Item size : 69052 bytes

Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

Date : 17/03/2019

Galectin 3 in patients with atrial fibrillation and metabolic syndrome

Date : 21/06/2015

C(-915)G polymorphism gene of transforming growth factor 1 in patients with metabolic syndrome and atrial fibrillation

Date : 28/08/2017

Epicardial fat and effectiveness of catheter radiofrequency ablation in patients with atrial fibrillation and metabolic syndrome

Date : 09/12/2016